Brought to you by 
Arthrex to market and distribute ECM products for Kensey Nash
27 May 2015
Executive Summary
Regenerative medicine firm Kensey Nash Corp. will use its Optrix extracellular matrix (ECM) technology to develop porcine dermis-derived surgical meshes, which sports medicine company Arthrex Inc. will market and distribute for use in tendon repair procedures and small joint surgeries.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Arthrex to market and distribute ECM products for Kensey Nash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice